Basic info
Industry
biotechnology research
Sectors
Biotechnology
Rhinovirus
Respiratory syncytial virus
Synthetic Biology
Infectious Diseases
Vaccines
Reverse Genetics
human metapneumovirus
Health Care
Parainfluenza
Date founded
2014
Funding rounds raised
Total raised
$30M
from 2 investors over 2 rounds
M
Meissa Vaccines raised $30M on September 26, 2019
Investors: Morningside Venture Capital 晨兴资本 and MBX Capital